SCM
CYTR

Stevens Capital Management’s CytRx Corp CYTR Stock Holding History

Stevens Capital Management’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,725
Closed -$43K – 1449
2014
Q2 		$43K Sell
1,725
-2,028
-54% -$46.2K ﹤0.01% 1024
2014
Q1 		$79K Buy
+3,753
New +$133K ﹤0.01% 1021

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Stevens Capital Management's CYTR Position: Q3 2014 in Review

Stevens Capital Management sold out of CytRx Corp (CYTR) in Q3 2014, closing a stake of 1,725 shares — an estimated $43K sold.

Stevens Capital Management first reported a position in CYTR in Q1 2014 and held it in 2 quarters. The position peaked at $79K in Q1 2014. 69 funds tracked by Wall St. Rank hold CYTR as of Q3 2014.

  • Stevens Capital Management reported no remaining CytRx Corp position as of Q3 2014 after selling out during the quarter.
  • Stevens Capital Management sold 1,725 CytRx Corp shares in Q3 2014, an estimated $43K.
  • Stevens Capital Management first reported a position in CytRx Corp in Q1 2014 and held it in 2 quarters.
  • Stevens Capital Management's CytRx Corp position peaked at $79K in Q1 2014.
  • 69 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2014.

Based on Stevens Capital Management's 13F filing for Q3 2014, filed 7 Nov 2014.